• 1
    Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008; 38: 6418.
  • 2
    Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir 2004; 59: 99111.
  • 3
    Tsukuma H, Ajiki W, Ioka A, Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 2006; 36: 6027.
  • 4
    De Braud F, Cascinu S, Gatta G. Cancer of pancreas. Crit Rev Oncol Hematol 2004; 50: 14755.
  • 5
    Agarwal B, Correa AM, Ho L. Survival in pancreatic carcinoma based on tumor size. Pancreas 2008; 36: e1520.
  • 6
    Pongprasobchai S, Pannala R, Smyrk TC et al. Long-term survival and prognostic indicators in small (<or=2 cm) pancreatic cancer. Pancreatology 2008; 8: 58792.
  • 7
    Freeny PC, Marks WM, Ryan JA, Traverso LW. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 1988; 166: 12533.
  • 8
    Legmann P, Vignaux O, Dousset B et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170: 131522.
  • 9
    Prokesch RW, Schima W, Chow LC, Jeffrey RB. Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance. Eur Radiol 2003; 13: 214754.
  • 10
    Bronstein YL, Loyer EM, Kaur H et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 2004; 182: 61923.
  • 11
    Cavanaugh D, Johnson E, Price RE, Kurie J, Travis EL, Cody DD. In vivo respiratory-gated micro-CT imaging in small-animal oncology models. Mol Imaging 2004; 3: 5562.
  • 12
    Li XF, Zanzonico P, Ling CC, O’Donoghue J. Visualization of experimental lung and bone metastases in live nude mice by X-ray micro-computed tomography. Technol Cancer Res Treat 2006; 5: 14755.
  • 13
    Hori Y, Takasuka N, Mutoh M et al. Periodic analysis of urethane-induced pulmonary tumors in living A/J mice by respiration-gated X-ray microcomputed tomography. Cancer Sci 2008; 99: 17747.
  • 14
    Bakan DA, Weichert JP, Longino MA et al. Polyiodinated triglyceride lipid emulsions for use as hepatoselective contrast agents in CT: effects of physicochemical properties on biodistribution and imaging profiles. Invest Radiol 2000; 35: 15869.
  • 15
    Konishi Y, Mizumoto K, Kitazawa S, Tsujiuchi T, Tsutsumi M, Kamano T. Early ductal lesions of pancreatic carcinogenesis in animals and humans. Int J Pancreatol 1990; 7: 839.
  • 16
    Pour P, Althoff J, Kruger FW, Mohr U. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. J Natl Cancer Inst 1977; 58: 144953.
  • 17
    Mizumoto K, Tsutsumi M, Denda A, Konishi Y. Rapid production of pancreatic carcinoma by initiation with N-nitroso-bis(2-oxopropyl)amine and repeated augmentation pressure in hamsters. J Natl Cancer Inst 1988; 80: 15647.
  • 18
    Ford NL, Graham KC, Groom AC, Macdonald IC, Chambers AF, Holdsworth DW. Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner. Invest Radiol 2006; 41: 38490.
  • 19
    Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB Jr. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 2002; 224: 7648.
  • 20
    Baron RL. Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 1994; 163: 32331.
  • 21
    Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006; 79: 24853.